Taevas
PolandMedical Devices
Product Registration
Market Access for Product-Registration in Poland
Navigating the intricate landscape of global product registration requires a robust market access strategy. Taevas Life Sciences provides comprehensive solutions to ensure your innovative products achieve optimal market entry and sustained commercial succ
Market
Global
Industry
Product-Registration
Regulator
International Regulatory Bodies & Local Health Authorities
Timeline
8-12 weeks (initial strategy)
Deliverables
Strategic Market Access Plan, Pricing & Reimbursement Dossier Guidance, Stakeholder Engagement Roadmap
What We Deliver
6 Pillars of Market Access
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Global Regulatory Intelligence & Landscape Analysis
We provide in-depth analysis of the complex and evolving regulatory requirements across target global markets, identifying critical pathways and potential hurdles for product registration.
Comprehensive regulatory pathway mapping
Risk assessment and mitigation strategies
How It Works
How It Works
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1-2
Discovery & Scope Definition
We begin with a comprehensive assessment of your product, therapeutic area, and target markets to define the project scope and key objectives. This ensures a tailored approach to your unique needs.
Market Snapshot
Market Overview: Global + Product-Registration
Increasing Regulatory Divergence
Global markets are experiencing growing divergence in regulatory requirements, HTA methodologies, and pricing policies, demanding highly specialized strategies for successful product registration and market entry.
Value-Based Access Imperative
Payers globally are increasingly demanding evidence of real-world value and cost-effectiveness. Products must demonstrate clear clinical and economic benefits to secure favorable reimbursement and broad patient access.
Digital Transformation in Access
The adoption of digital health technologies and real-world data is reshaping market access strategies, offering new avenues for evidence generation, patient engagement, and accelerated pathways.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Comprehensive Market Access Strategy Report
A detailed report outlining regulatory pathways, HTA considerations, pricing recommendations, and stakeholder engagement plans for your target markets.
Reimbursement Dossier Preparation Guidelines
Expert guidance and templates to compile robust reimbursement dossiers that meet the specific requirements of key global payers and HTA bodies.
Global Stakeholder Engagement & Communication Plan
A strategic plan for identifying and engaging with critical stakeholders, including patient advocacy groups, medical societies, and policymakers, to build support for your product.
Who This Is For
Use Cases
New Market Entry
Launching a Novel Therapeutic in Emerging Markets
A biotech company with a breakthrough oncology drug needed to navigate diverse regulatory and reimbursement landscapes across Asia and Latin America for its first global launch.
Outcome
Taevas developed a phased market access strategy, securing registration and favorable reimbursement in multiple key markets within 18 months.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Start Market Access in Global?
Partner with Taevas Life Sciences to transform your global product registration challenges into market access triumphs. Let our expertise pave the way for your commercial success.
Navigate Global Complexities
Maximize Commercial Potential
Accelerate Patient Access
Mitigate Regulatory Risks